ML
MED icon

McAdam LLC’s Medifast MED Stock Holding History

McAdam LLC’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6
Closed -$1K – 740
2018
Q1 		$1K Buy
+6
New +$448 ﹤0.01% 668

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

McAdam LLC's MED Position: Q2 2018 in Review

McAdam LLC sold out of Medifast (MED) in Q2 2018, closing a stake of 6 shares — an estimated $1K sold.

McAdam LLC first reported a position in MED in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 258 funds tracked by Wall St. Rank hold MED as of Q2 2018.

  • McAdam LLC reported no remaining Medifast position as of Q2 2018 after selling out during the quarter.
  • McAdam LLC sold 6 Medifast shares in Q2 2018, an estimated $1K.
  • McAdam LLC first reported a position in Medifast in Q1 2018 and held it in 1 quarter.
  • McAdam LLC's Medifast position peaked at $1K in Q1 2018.
  • 258 funds tracked by Wall St. Rank held Medifast as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.